Logiscreen

Amneal Pharmaceuticals Inc - Class A

$13.75
Market Cap 4.33B
ROE -144.6%
Gross Margin 44.3%
Debt/Equity -59.4
Current Ratio 2.5
Revenue QoQ 3.9%
EPS QoQ 4.0%
F-Score 5

About

Amneal Pharmaceuticals Inc. Class A

Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Fair Value

Trading at a discount to sector peers

P/E
34.83
vs median 31.50
P/B
-93.67
vs median 2.17
ROE
-1.45
vs median 0.09

Decent quality with acceptable fundamentals

Mid-cap company with growth potential

Similar companies

INDVSUPNPBHAVDLDCPHBHC
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics